Scientific Advisory Committee
The Scientific Advisory Committee, or SAC, is an independent body within CEPI. It is one of CEPI's core governance groups alongside the Board, Investors Council and Joint Coordination Group.
How they work
The SAC provides scientific support, advice and challenge to the CEPI Leadership and Board on a range of scientific issues related to vaccine research and development and manufacturing to support the effective implementation of CEPI’s strategic objectives.
Recent discussions
CEPI's Scientific Advisory Committee meet regularly to discuss and provide support, advice and challenge to CEPI's Leadership and Board.
SAC Members
Chair: Dr Laura Palomares Aguilera – Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), Mexico
Vice-Chair: Professor Michael King – University of Virginia, USA
- Associate Professor Ifedayo Adetifa, FIND, Switzerland
- Emeritus Professor Vineeta Bal – Indian Institute of Science Education and Research, Pune, India
- Dr Rick A. Bright – Bright Global Health, USA
- Assistant Professor Yunlong Cao – Peking University, China
- Dr Marco Cavaleri, European Medicines Agency (EMA), The Netherlands
- Dr Lin H. Chen, Mount Auburn Hospital and Harvard Medical School, USA
- apl. Professor Dr Klaus Cichutek, Former President, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany
- Dr Peter Dull – Bill & Melinda Gates Foundation, USA
- Professor Azra Ghani – Imperial College London, United Kingdom
- Dr Paula Goldin - Thermo Fisher, Argentina
- Dr Rebecca Grais – Pasteur Network, France
- Dr Joanke Graveland-Bikker, Independent Consultant, The Netherlands
- Dr Beth-Ann Griswold Coller - BGC Consulting, USA
- Professor Ken J. Ishii – International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Japan
- Professor Amine Kamen – McGill University, Canada
- Professor Kevin Kee-Jong Hong – Korea mRNA Vaccine Initiative, Korea
- Dr Luciana C. C. Leite - Instituto Butantan, Brazil
- Professor Marc Lipsitch - Stanford University, USA
- Mr Dominique Maugeais – RH Solutions, France
- Dr Placide Mbala-Kingebeni - Institut National de Recherche Biomedicale, Democratic Republic of Congo
- Mr Sly Mutyavaviri - Medicines Control Authority of Zimbabwe and SADC Medicines Regulatory Harmonisation, Zimbabwe
- Dr Peter Paradiso – Paradiso Biologics Consulting, LLC, USA
- Professor Rino Rappuoli – Fondazione Biotecnopolo di Siena, Italy
- Dr Joseph D. Santangelo, Takeda Pharmaceuticals, USA
- Dr Vaseeharan Sathiyamoorthy, World Health Organization (WHO), Switzerland
- Dr Andre Siqueira - Fundação Oswaldo Cruz (Fiocruz), Brazil
- Dr Lynda Stuart - Fund for Science and Technology (FFST), USA
- Professor Petro Terblanche, Afrigen Biologics, South Africa
- Professor Linfa Wang – Duke-NUS Medical School, Singapore
- Professor George Warimwe – KEMRI-Wellcome Trust Research Programme, Kenya and University of Oxford, United Kingdom
- Dr William Warren, WKLW Consulting LLC, USA
Joint Coordination Group
Our Joint Coordination Group, or JCG, is a roundtable of independent institutions with an interest in seeing CEPI-funded vaccines successfully developed and deployed in an outbreak.
Portfolio Strategy and Management Board
The PSMB is the decision-making body accountable for identification, selection, management and evaluation of CEPI’s R&D and Manufacturing portfolio.
